News FDA Approves First Treatment for Thyroid Eye Disease by Medscape • 2020/01/22 • 0 Comments The monoclonal antibody teprotumumab reduces proptosis and related eye problems in patients with thyroid-associated ophthalmopathy. FDA Approvals Full Story →